Vericel (VCEL) Cost of Revenue (2011 - 2026)
Vericel (VCEL) reported Cost of Revenue of $19.2 million for Q1 2026, up 17.36% on a YoY basis from $16.3 million in Q1 2025, and down 3.19% sequentially from $19.8 million in Q4 2025.
Vericel (VCEL) Cost of Revenue (2011 - 2026) Analysis & Trends
Vericel (VCEL) has 16 years of Cost of Revenue data on file, last reported at $19.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue rose 17.36% year-over-year to $19.2 million; the trailing twelve-month figure through Mar 2026 stood at $73.5 million (up 12.18% YoY), and the FY2025 full-year result was $70.7 million, up 8.51% from the prior year.
- Cost of Revenue eased to $19.2 million in Q1 2026, from $19.8 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $19.8 million in Q4 2025 to a low of $12.6 million in Q1 2022.
- A 5-year average of $16.0 million and a median of $16.1 million in 2024 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue rose 0.5% in 2024 and increased 17.36% in 2026, its largest moves.
- Tracing VCEL's Cost of Revenue over 5 years: stood at $14.4 million in 2022, then advanced by 14.15% to $16.5 million in 2023, then increased by 2.35% to $16.9 million in 2024, then advanced by 17.26% to $19.8 million in 2025, then decreased by 3.19% to $19.2 million in 2026.
- Business Quant data shows VCEL's Cost of Revenue at $19.2 million in Q1 2026, $19.8 million in Q4 2025, and $17.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Vericel | 2.33 Bn | 2.18 Bn | 49.27 Mn | 19.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.16 Mn |
| Mar 31, 2026 | 19.16 Mn |
| Dec 31, 2025 | 19.79 Mn |
| Dec 31, 2025 | 19.79 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Jun 30, 2025 | 16.63 Mn |
| Jun 30, 2025 | 16.63 Mn |
| Mar 31, 2025 | 16.33 Mn |
| Mar 31, 2025 | 16.33 Mn |
| Dec 31, 2024 | 16.88 Mn |
| Dec 31, 2024 | 16.88 Mn |
| Sep 30, 2024 | 16.25 Mn |
| Sep 30, 2024 | 16.25 Mn |
| Jun 30, 2024 | 16.06 Mn |
| Jun 30, 2024 | 16.06 Mn |
| Mar 31, 2024 | 15.93 Mn |
| Mar 31, 2024 | 15.93 Mn |
| Dec 31, 2023 | 16.49 Mn |
| Dec 31, 2023 | 16.49 Mn |